74 results
424B1
VVOS
Vivos Therapeutics Inc
26 Apr 24
Prospectus with pricing info
5:07pm
, it is time to focus our resources and efforts on the source of where the vast majority of OSA patients are first diagnosed and treated—the medical … , holders of a majority of the shares of common stock voting for the election of directors can elect all of the directors. Holders of our common stock
8-K
EX-4.2
VVOS
Vivos Therapeutics Inc
15 Feb 24
Entry into a Material Definitive Agreement
8:55am
by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably … by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall
8-K
EX-4.1
wnhdalfpy0ou
15 Feb 24
Entry into a Material Definitive Agreement
8:55am
8-K
EX-10.1
8ty53ua08w
15 Feb 24
Entry into a Material Definitive Agreement
8:55am
424B1
eq2e40i
1 Dec 23
Prospectus with pricing info
4:12pm
8-K
EX-4.1
3ahzcmyo4q9vyb586
2 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-4.2
mfhe n6dex6e
2 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.2
bbi2z nwa
2 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-4.4
gf5 zv2xz5o
2 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
fczbv2 2u
2 Nov 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-3.1
ao2htqgv3v0g061vt5s
27 Oct 23
Material Modifications to Rights of Security Holders
4:15pm
DEFA14A
63o65 ynx
6 Sep 23
Additional proxy soliciting materials
5:26pm
PRE 14A
zhtxjwz2 8r
16 Aug 23
Preliminary proxy
4:45pm